Cargando…
Short-term regression of corneal neovascularization with combination therapy of argon green laser photocoagulation and subconjunctival bevacizumab
We present a case of a 49 year-old male with history of corneal neovascularization secondary to herpes zoster keratitis that clinically and subjectively improved for approximately 4 months after treatment with argon laser photocoagulation to feeder vessels and subconjunctival bevacizumab. This is th...
Autores principales: | Anand, Nandita, Reidy, James J, Riaz, Kamran M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6489666/ https://www.ncbi.nlm.nih.gov/pubmed/31114395 http://dx.doi.org/10.2147/IMCRJ.S195990 |
Ejemplares similares
-
Subconjunctival bevacizumab and argon laser photocoagulation for preexisting neovascularization following deep lamellar anterior keratoplasty
por: Lakshmipathy, Meena, et al.
Publicado: (2019) -
Resolution of Refractory Corneal Neovascularization with Subconjunctival Bevacizumab
por: Britton, Anna Krystyna, et al.
Publicado: (2020) -
Regression of Iris Neovascularization after Subconjunctival Injection of Bevacizumab
por: Ryoo, Na Kyung, et al.
Publicado: (2013) -
Successful regression of newly formed corneal neovascularization by subconjunctival injection of bevacizumab in patients with chemical burns
por: Peng, Wen-yan, et al.
Publicado: (2023) -
The effect of subconjunctival bevacizumab on corneal neovascularization, inflammation and re-epithelization in a rabbit model
por: Mello, Glauco Reggiani, et al.
Publicado: (2011)